AstraZeneca’s Tezspire succeeds in late-stage esophagitis trial
AstraZeneca says its asthma drug Tezspire succeeded in a late-stage esophagitis trial.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.